| ||||||||||||||
|
|
|||||||||||||



*Department of Anesthesiology, Pitié-Salpétrière Hospital;
EFS, Site Pitié-Salpétrière, Pitié-Salpétrière Hospital; and
Department of Vascular Surgery, Pitié-Salpétrière Hospital, Paris, France
Address correspondence and reprint requests to Prof. Jean-François Baron, Département dAnesthésie Réanimation, Hôpital Pitié-Salpétrière, 47-83 Bd. de lHôpital, 75013 Paris, France. Address e-mail to jfbaron{at}club-internet.fr
We evaluated, by using a before-and-after study, the influence of leukoreduction by filtration on postoperative infections and adverse outcomes in patients undergoing elective major aortic surgery. From January 1995 to October 2000, all patients who underwent elective abdominal aortic surgery were included in the analysis. Before the introduction of systematic leukodepletion of packed red blood cells (RBCs), on April 1, 1998, 192 patients received standard or buffy-coat-depleted packed RBCs. Then, 195 patients were transfused with exclusively filtered leukodepleted packed RBCs. No major significant difference was observed between the groups of patients with regard to preoperative cardiac and pulmonary status, anesthetic and surgical techniques, or transfusion policy. No significant difference in mortality was observed between the two groups. The incidence of postoperative infections was 31% (95% confidence interval, 25%38%) in the Control group versus 27% (95% confidence interval, 21%33%) in the Leukodepleted group; severe infectious complications and pneumonia were not significantly different between the two groups of patients. Cardiovascular and respiratory outcomes were not significantly different between the groups. Data from this study suggest that the effect of using leukodepleted RBC on postoperative infections is not of obvious importance.
IMPLICATIONS: We evaluated the influence of leukocyte reduction by filtration of packed red blood cells (RBC) on postoperative infections and adverse outcomes in patients undergoing elective major aortic surgery by comparing two epochs with and without filtration. Data from this study suggest that the effect of using filtered RBC on postoperative infections is not of obvious importance.
This article has been cited by other articles:
![]() |
G. Netzer, C. V. Shah, T. J. Iwashyna, P. N. Lanken, B. Finkel, B. Fuchs, W. Guo, and J. D. Christie Association of RBC Transfusion With Mortality in Patients With Acute Lung Injury Chest, October 1, 2007; 132(4): 1116 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Spiess Transfusion of Blood Products Affects Outcome in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 267 - 281. [Abstract] [PDF] |
||||
![]() |
D. Fergusson, M. P. Khanna, A. Tinmouth, and P. C. Hebert Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials: [La transfusion de sang reduit en leucocytes peut diminuer les infections postoperatoires : deux meta-analyses d'etudes randomisees et controlees] Can J Anesth, May 1, 2004; 51(5): 417 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Hebert, D. Fergusson, M. A. Blajchman, G. A. Wells, A. Kmetic, D. Coyle, N. Heddle, M. Germain, M. Goldman, B. Toye, et al. Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions JAMA, April 16, 2003; 289(15): 1941 - 1949. [Abstract] [Full Text] [PDF] |
||||
|